Singapore's pharma and electronics sectors drove strong momentum through Q4 2025, lifting the full-year growth to levels not seen since the post-pandemic recovery kicked in. The manufacturing backbone proved resilient even as global supply chains faced ongoing pressures. For investors tracking macroeconomic signals, this uptick in Asia-Pacific industrial output signals continued momentum in key production hubs. The data underscores how traditional manufacturing strength remains a crucial indicator for gauging broader economic health—something worth watching alongside crypto market cycles and asset rotation strategies. Full-year performance now stands as one of the strongest showings for the city-state in recent years.